These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12422715)

  • 21. [After prohibition of dose aerosol inhalers with FCKW. Powder inhaler improves steroid therapy].
    MMW Fortschr Med; 2003 Mar; 145(11):61. PubMed ID: 12688205
    [No Abstract]   [Full Text] [Related]  

  • 22. Switching to CFC-free inhalers.
    Weller T
    Prof Nurse; 1999 Nov; 15(2):73. PubMed ID: 10765307
    [No Abstract]   [Full Text] [Related]  

  • 23. Bronchial reactions to aerosol inhalant vehicle.
    Bryant DH; Pepys J
    Br Med J; 1976 May; 1(6021):1319-20. PubMed ID: 1268679
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of beclomethasone dipropionate aerosolized through different nebulizers to asthmatic patients.
    Terzano C; Guerra S; Allegra L
    Eur Rev Med Pharmacol Sci; 2001; 5(2):43-51. PubMed ID: 11863318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebulisers and paradoxical bronchoconstriction.
    Lancet; 1988 Jul; 2(8604):202. PubMed ID: 2899670
    [No Abstract]   [Full Text] [Related]  

  • 26. Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers: potential advantages and disadvantages.
    Tashkin DP
    Chest; 1999 Feb; 115(2):316-8. PubMed ID: 10027423
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in metered dose inhaler propellants].
    Chinet T
    Rev Mal Respir; 2000 Feb; 17(1):15-20. PubMed ID: 10756552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic approach to the distal airways in asthma].
    de Diego Damiá A; Vega Chicote JM
    Arch Bronconeumol; 2011 Apr; 47 Suppl 2():27-31. PubMed ID: 21640282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vivo and in vitro comparison of inhaled steroid delivery via a novel vortex actuator and a conventional valved holding chamber.
    Menzies D; Nair A; Fardon T; Barnes M; Burns P; Lipworth B
    Ann Allergy Asthma Immunol; 2007 May; 98(5):471-9. PubMed ID: 17521032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.
    Dutoit JI; Salome CM; Woolcock AJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1174-8. PubMed ID: 3674580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Your metered-dose inhaler will be changing: here are the facts. National Asthma Education and Prevention Program.
    Am J Health Syst Pharm; 1998 Feb; 55(3):276-8. PubMed ID: 9492259
    [No Abstract]   [Full Text] [Related]  

  • 32. The functional benefit of anti-inflammatory aerosols in the lung periphery.
    Verbanck S; Schuermans D; Paiva M; Vincken W
    J Allergy Clin Immunol; 2006 Aug; 118(2):340-6. PubMed ID: 16890756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrofluoroalkane-beclomethasone versus chlorofluorocarbon-beclomethasone delivery in neonatal models.
    Cole CH; Mitchell JP; Foley MP; Nagel MW
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F417-8. PubMed ID: 15321960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Counseling about chlorofluorocarbon-free inhalers.
    Breitigan JM
    Am J Health Syst Pharm; 1998 Feb; 55(3):226-7. PubMed ID: 9492253
    [No Abstract]   [Full Text] [Related]  

  • 36. Matching the device to the patient.
    Tiddens H
    Pediatr Pulmonol Suppl; 2004; 26():26-9. PubMed ID: 15029584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bronchial reactivity as factor of effectiveness of new antiasthmatic drugs].
    Pol'ner SA; Chervinskaia TA
    Ter Arkh; 2000; 72(3):20-3. PubMed ID: 10776647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of beclomethasone dipropionate in an hydrofluoroalkane-134a propellant system in Japanese children with bronchial asthma.
    Teramoto T; Fukao T; Tomita Y; Terauchi Y; Hosoi K; Matsui E; Aoki M; Kondo N; Mikawa H
    Allergol Int; 2006 Sep; 55(3):317-20. PubMed ID: 17075274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
    Boulet LP
    Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
    Harrison LI
    J Aerosol Med; 2002; 15(4):401-6. PubMed ID: 12581506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.